基托基纳米颗粒的体内毒性:系统性审查
Shela Salsabila1, Miski Aghnia Khairinisa2, Nasrul Wathoni3
1Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Padjadjaran University, Sumedang, Indonesia.
Artificial cells, nanomedicine, and biotechnology
|February 10, 2025
概括
素纳米颗粒显示了药物输送的有利安全概况. 毒性研究显示,在各种给药途径中,LD50值高,副作用最小.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 基托桑纳米颗粒被广泛用作聚合物药物载体.
- 它们在改善药物输送,疗效和安全方面的潜力是众所周知的.
- 综合性毒性评估对于其临床应用至关重要.
研究的目的:
- 审查基托桑基纳米颗粒在药物输送中的安全性.
- 专注于一般的毒性测试,包括LD50和NOAEL值.
- 作为基托桑纳米颗粒药物递送系统未来研究和开发的参考.
主要方法:
- 2014-2024年出版物的系统文献综述.
- 搜索的数据库:PubMed,Scopus,谷歌学者,科学直接.
- 使用ARRIVE 2.0指南进行质量和偏差风险评估的体内毒性研究的评估.
主要成果:
- 素纳米颗粒通常表现出有利的毒性概况.
- 急性毒性研究报告了高的LD50值 (通常>5000毫克/公斤).
- 亚急性研究表明,在各种管理途径 (口服,静脉注射,IP,吸入,局部) 中没有显著的不良影响.
结论:
- 素纳米颗粒在药物输送应用中显示出有前途的安全性.
- 与免费药物或物质相比,它们的毒性通常较低.
- 这些发现支持在制药配方中继续开发素纳米颗粒.
相关概念视频
Toxic Reactions: Overview
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...


